Bits and pieces

Can we take a moment to talk about the elephant in the room? Last week Jeff Sessions rescinded the Cole Memo, which was put in place by President Obama. This memo protected states with legalized marijuana from federal prosecution. As has been mentioned before, CBD got tossed under the bus with cannabis in 2016 and is being called a Schedule 1 substance by the Drug Enforcement Administration. But, let’s not panic. This FAQ from Leafly.com can help give you perspective.

Basically, the article says that, for the moment, it’s business as usual. But, at the same time, your lawmakers need to know your stance on cannabis and CBD. Read the article and then decide your next step.

$3.2 million hemp processing plant in New York gets state funding

Following on the previous snippet, we get this news. It tells me that despite the administration, there is a strong case being made by movers and shakers to dispel the myths about CBD, hemp and even marijuana. The processing plant, funded by the government is, according to Gov. Andrew Cuomo, one of the first of its kind. The plant will prepare hemp fibers and oils for further manufacturing.

CBD primer

I found this primer about cannabidiol and the benefits of CBD, written by David Bearman, M.D. He makes a case for more research because of the amount of existing evidence that already shows the therapeutic benefits of CBD and cannabis. Although the government (think Sessions) is being a bit noisy about cannabadiols, Bearman also gives us insight into a number of ways the government is studying it quietly. There is a lot that is already known about cannabis that has not made it to the mainstream. The article also breaks down which conditions benefit most from cannabis. It’s an interesting article that I think will clarify a lot of questions you may have.

Finally, in case you don’t have time to read the articles, here are a couple of visual aids that can show the value of CBD in a nutshell.

Blog image.jpg
Blog image 2.jpg